Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spinal Cord Injuries × OM 89 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Tract Infections 1 Urinary Bladder, Neurogenic 1 Spinal Cord Injuries 1 Myelitis, Transverse 1 Multiple Sclerosis 1

Interventions

rimabotulinumtoxinB 1 OM 89 1 Neurofeedback 1 N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide 1 Music Therapy 1 Cholecalciferol 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02591901 2020-03-18

PReSuTINeB

Buckinghamshire Healthcare NHS Trust

Phase 2 Completed

Urinary Bladder, Neurogenic, Multiple Sclerosis, Myelitis, Transverse, Spinal Cord Injuries, Urinary Tract Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡